Value Bridge — NORTH OAKS MEDICAL CENTER
Current $23M → Target $29M (+$6.2M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$23.1M
Current EBITDA
$29.3M
Target EBITDA
+$6.2M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.4M
Payer Mix Optimization
$3.4M
Cost to Collect Reduction
$1.1M
Clean Claim Improvement
$0.8M
Volume & Rate Growth
$5.6M
What This Means
The 7-lever model projects a 27% EBITDA uplift from $23M to $29M. The highest-impact lever is Volume & Rate Growth at $2.2M probability-weighted.
IC talking point: "We see $6M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $68M in equity value creation."